favezelimab (MK-4280) - Merck (MSD)
Keytruda (pembrolizumab) - Merck (MSD)
https://library.ehaweb.org/eha/2024/eha2024-congress/420153/david.lavie.favezelimab.28anti-lag-329.plus.pembrolizumab.28pembro29.in.patients.html?f=menu%3D6%2Abrowseby%3D8%2Asortby%3D2%2Ace_id%3D2552%2Aot_id%3D29170%2Amarker%3D5100%2Afeatured%3D18527
 
Nathalie Johnson; Armando Santoro; Yair Herishanu; Philippe Armand; John Kuruvilla; Charalambos Andreadis; Abraham Avigdor; Michael Koontz; Leonard Minuk; Kerry Savage; Rachel Marceau West; Pallavi Pillai; Patricia Marinello; David Lavie
 
May 15, 2024
 
Next